Jonathan E. Lim - 05 Oct 2023 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role: Chairman & CEO, Director, 10%+ Owner
Signature: /s/ Ebun Garner, attorney-in-fact
Issuer symbol: ERAS
Transactions as of: 05 Oct 2023
Net transactions value: +$2,026,000
Form type: 4
Filing time: 10 Oct 2023, 08:00:07 UTC
Previous filing: 08 Jun 2023
Next filing: 06 Dec 2023
SEC: View on sec.gov

Key filing fact

Jonathan E. Lim filed Form 4 for Erasca, Inc. (ERAS) on 10 Oct 2023.

Key facts

This page summarizes Jonathan E. Lim's Form 4 filing for Erasca, Inc. (ERAS).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 10 Oct 2023, 08:00.

Change

Previous filing in this sequence was filed on 08 Jun 2023.
Current net transaction value: +$2,026,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

ERAS transaction

Common Stock

Purchase

Transaction value: $2,026,000
Shares: +1,000,000
Change %: +5.4%
Price: $2.03
Shares after: 19,456,216
Date: 05 Oct 2023
Ownership: By Jonathan E. Lim and Conyee T. lim Family Trust, dated April 28, 2005
Footnotes: F1

ERAS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,899,360
Date: 05 Oct 2023
Ownership: By City Hill, LLC
Footnotes: F2

An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F2	Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.

Content

The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.

Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.